Comparing short versus longer steroid treatment for severe pneumonia
Part of Infections, Lungs & breathing clinical trials.
This study compares two different lengths of steroid treatment for people with severe Pneumocystis pneumonia (a serious lung infection). If you have improved enough by day 10 to breathe without oxygen, the study will see if stopping steroids sooner is as safe and effective as continuing them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a confirmed or likely case of Pneumocystis pneumonia (a type of lung infection).
- Your infection is severe enough that you need extra oxygen (at least 4 liters per minute or a similar amount).
- You are already taking or planning to take steroids as part of your treatment.
- By the 10th day of steroid treatment, you can breathe room air (without extra oxygen) for at least 6 hours at a time.
- You are able to give informed consent and attend follow-up visits for 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether short-term steroid treatment helps adults with a specific lung infection (PCP) that happens with HIV/AIDS. It compares outcomes in people who start steroids soon after admission while also taking standard PCP antibiotics.
This trial tests whether giving steroids (anti-inflammatory medicines) to people with a severe lung infection called Pneumocystis pneumonia (PJP) can improve outcomes. It is for patients who are in the ICU and do not have HIV, which is a different group than typical PJP patients.
This study compares different second-line antibiotics for treating Pneumocystis pneumonia (a serious lung infection) in people with weakened immune systems. It aims to find the best alternative when the standard treatment cannot be used.
This study tests whether giving a personalized dose of steroids (anti-inflammatory medicine) early can help people with severe pneumonia-related breathing failure recover faster. It compares different steroid doses based on your body's inflammation and immune response.
This study tests whether giving a standard steroid medication (a type of anti-inflammatory drug) helps people with severe breathing infections recover faster and breathe better. If you qualify, you would receive either the steroid or a placebo while you're in the hospital.
This trial compares two common steroid medicines, hydrocortisone and prednisolone, to see which works better for people with severe community-acquired pneumonia. It aims to find the best treatment to help you recover faster.
Hear when a new Pneumocystis Pneumonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.